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MAPKS ARE ESSENTIAL UPSTREAM SIGNALING
PATHWAYS IN PROTEOLYTIC DEGRADATION -
DIVERGENCE IN PATHWAYS LEADING TO AGGRECANASE
AND MMP MEDIATED ARTICULAR CARTILAGE
DEGRADATION
B.-C. Sondergaard, N. Schultz, S.H. Madsen, A.C. Bay-Jensen,
M.A. Karsdal
Nordic BioSci., Herlev, Denmark
Purpose: Matrix metalloproteinases (MMP) and aggrecanases
are essential players in cartilage degradation and the expression
and activity of these enzymes is highly increased under degen-
erative diseases like osteoarthritis (OA). The signaling pathways
that results in either MMP or aggrecanase biosynthesis and ac-
tivation are not well understood and described. We investigated
the molecular events leading to MMP and aggrecanase-mediated
cartilage degradation by inhibition of speciﬁc signaling pathways.
Methods: Cartilage degradation was induced in bovine articular
cartilage explants by oncostatin M (OSM) and transforming necro-
sis factor alpha (TNF), in the presence or absence of speciﬁc
inhibitors of the mitogen-activated protein kinases (MAPK) P38,
P44/42 and Src family. The inhibitors were used in the catabolic
stimulated cultures in concentrations of 0, 0.1, 1 and 10 μM of
MAPK P38 pathway were SB203580 & SB202190, inhibitors of
the P44/42 pathway were PD98059 & U0126, and ﬁnally PP1
were used as inhibitor of the Src family. Toxicity toward cell viabil-
ity by the inhibitors was followed by the AlamarBlue colorimetric
assay. The total MMP-activity was assessed using a ﬂuorescent
substrate assay and the gelatinase activity of MMP-9 and -2 by
gelatin zymography. MMP-mediated collagen type II degradation
(CTX-II ELISA) and MMP (342-G2 ELISA) as well as aggrecanase-
mediated aggrecan degradation (374-G2 ELISA) was investigated
with speciﬁc ELISA and hydroxyproline release by standard meth-
ods. The ﬁndings were veriﬁed by immunohistochemistry and
histology.
Results: Stimulation of cartilage degradation by OSM + TNF
resulted in 100-fold induction of CTX-II release (P<0.01). This
was dose-dependently inhibited by MAPK P38 inhibitors and
by the MAPK P44/42 inhibitors (P<0.01). MMP-activity and ex-
pression was signiﬁcantly decreased, as evaluated by cleavage
of ﬂuorescence MMP substrate and zymography (P<0.01). Im-
munohistochemistry using an antibody detecting collagen type II
degradation and toluidine blue staining of aggrecan conﬁrmed
these ﬁndings. Interestingly, the P44/42 inhibitors abrogated both
aggrecanase-mediated aggrecan degradation (374-G2 ELISA)
(P<0.01), whereas P38 MAP kinase inhibitors had no effect.
Conclusions: We found that inhibition of MAPK P38, P44/42 and
Src family abrogated proteolytic cartilage degradation by blocking
MMP synthesis and activity. However, only MAPK P44/42 was
essential for aggrecanase-mediated aggrecan degradation. These
data suggest that various aspects of cartilage degradation can be
targeted independently by inhibiting of speciﬁc upstream signaling
pathway.
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ROLE OF PROTEIN KINASE C ISOFORMS IN
COLLAGENASE INDUCTION AND CARTILAGE
DEGRADATION
A.D. Rowan, G.J. Litherland
Inst. of cellular medicine, newcastle Univ., newcastle, United
Kingdom
Purpose: Degradation of articular cartilage is a major character-
istic of arthritic diseases such as rheumatoid and osteoarthritis
(OA). Pro-inﬂammatory cytokines such as interleukin-1 (IL-1) are
recognized to be important inﬂammatory mediators in these dis-
eases. IL-1 is a well known inducer of the collagenolytic matrix
metalloproteinases (MMPs) in human chondrocytes, and the col-
lagenases are key enzymes in the pathological destruction of
cartilage. IL-1 activates many signal transduction pathways in-
cluding Protein kinase C (PKC) which comprises a family of
serine/threonine protein kinases. These kinases control a variety
of cellular processes including tissue remodeling via the regulation
of MMP gene expression. This study therefore aimed to assess
the role of PKC signaling in collagenase induction in human chon-
drocytes. In particular, we evaluated the role of individual PKC
isoforms in collagenase gene expression.
Methods: An ex vivo model of cartilage degradation was used
with the most potent cytokine stimulus reported to promote car-
tilage catabolism, namely IL-1 in combination with oncostatin M
(OSM). These stimuli as well as the PKC activator, phorbol-12-
myristate-13-acetate (PMA) were used for isolated primary OA
chondrocytes. A range of pharmacological PKC inhibitors as well
as speciﬁc small interfering RNAs (siRNAs) were utilized, and
collagenase gene expression was assessed by real time PCR.
Results: PMA markedly enhanced both basal and cytokine-
stimulated expression of MMP-1 and MMP-13 in human chondro-
cytes, and phosphorylation of the classical PKC substrate, myris-
toylated alanine-rich C-kinase substrate (MARCKS) was stimu-
lated by IL-1+OSM. This phosphorylation was blocked by PKC
inhibitors, which also prevented collagenase induction and se-
cretion by chondrocytes. Moreover, PKC inhibition signiﬁcantly
reduced collagen release as well as both collagenolytic and
gelatinolytic activities in stimulated cartilage explants. System-
atic siRNA-mediated gene silencing of individual PKC isoforms
revealed that of the classical PKC (cPKC) isoforms, cPKCγ was
required for MMP-1, but not for MMP-13 induction by IL-1. Con-
versely, novel PKC (nPKC)-δ was required for MMP-13, but not
MMP-1 induction, whilst nPKCη was necessary for expression of
both collagenase genes. Of the atypical PKC (aPKC) isoforms, we
found that both aPKCζ and PKCι were important for IL-1 stimula-
tion of both MMP-1 and MMP-13. When the catabolic stimulus was
IL-1+OSM, the atypical aPKCζ and PKCι were again important for
collagenase gene expression.
Conclusions: Our data suggest that these isoforms may be
most applicable as potential therapeutic targets in the context
of an inﬂammatory milieu. These ﬁndings thus expand previous
knowledge regarding the roles of PKC isoforms in MMP gene
expression, and illustrate the limitations of single-stimulus studies
in evaluating potential therapeutic targets for regulation of MMP
genes.
